Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-016466
Filing Date
2025-05-13
Accepted
2025-05-13 16:15:56
Documents
55
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbrx20250331_10q.htm   iXBRL 10-Q 675670
2 EXHIBIT 31.1 ex_773672.htm EX-31.1 13417
3 EXHIBIT 31.2 ex_773673.htm EX-31.2 13133
4 EXHIBIT 32.1 ex_773674.htm EX-32.1 6692
5 EXHIBIT 32.2 ex_773675.htm EX-32.2 6753
11 moleculinnewlogoresized.jpg GRAPHIC 7783
  Complete submission text file 0001437749-25-016466.txt   3943072

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20250331.xsd EX-101.SCH 48369
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20250331_cal.xml EX-101.CAL 27918
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20250331_def.xml EX-101.DEF 261438
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20250331_lab.xml EX-101.LAB 246884
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20250331_pre.xml EX-101.PRE 286234
58 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20250331_10q_htm.xml XML 478953
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 25940345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)